“showed a trend”

Patients with hypertension in our series showed a trend towards a more frequent readmission (p=0.07).

Plasma lipid levels were similar between the transplanted groups; however, the concentration of IL-6 was diminished by 37% ( p = 0.05) while TNF-α plasma levels showed a trend to decrease (43%, p = 0.07) in the group that received bone marrow from the exercised mice ( Table 3 ).

No factors were associated with local and distant brain failure; however, combining systemic treatment and SRS showed a trend throughout of better distant brain control ( P = .07).

After a median follow-up of 3.8 (range, 0–11.5) years, patients with BRCA1/2 -mutated tumors showed a trend toward improved PFI and PFS as compared to those with BRCA1/2 -intact tumors (median survival: 17 vs. 6 months [HR, 0.48; 95% CI, 0.22–1.06; P=0.07] and 20 vs. 11 months [HR, 0.53; 95% CI, 0.26–1.09; P=0.08], respectively).

Indeed, in a meta-analysis of almost 29,000 patients with COVID-19, use of RAAS inhibitors for any condition showed a trend to lower risk of death or critical events (odds ratio 0.67, 95% CI 0.43 to 1.03, p = 0.07).

There is only one previous report of muscle biopsy analysis from the UL (deltoid) of 10 COPD patients, and this showed a trend ( P = 0.07) for lower citrate synthase activity compared with controls ( 24 ).

The mixed-model ANOVA analysis of P50 amplitude showed a trend toward a significant main effect of group ( F (1,25) = 3.58, p = 0.07) but no significant main effects of stimulus type or attention as well as no significant interactions between any of the factors ( Figure 2B ).

Similarly, QoL in terms of physical functioning and pain showed a trend towards improvement eight weeks after initiation of treatment compared with baseline ( P = 0.070 and 0.081, respectively) (Fig 3a ).

In support of this, Pol II signals showed a trend of increase at two of these enhancers ( p = 0.07–0.08) in response to FC (Supplementary Fig. 7a-c ), which are consistent with the earlier findings 16 ; although the Pol II difference between WT and Top3β-KO mice was not significant.

IL-13 and IL-25 were not significantly associated with any specific irAE but showed a trend toward higher fold change for enterocolitis irAEs ( Figure 4, C and D ; P = 0.07 and P = 0.05, respectively).

DHEA levels showed a trend towards being significantly higher in boys with more environment-related childhood adversity ( p = 0.07).

Moreover, SOX2-negative cases showed a trend for a longer survival time when compared to those expressing this factor (80 months (CI 69-92) vs 42 months (CI 25-59), respectively; HR 2,8; p = 0.07).

The PSP showed a trend of improvement at week 6 ( P = 0.07) and was significantly improved in both groups, beginning at week 12 of phase 2 ( F = 13.22, P = 0.0001, ES = 0.60).

When analyzed globally, beta diversity showed a trend towards a change in the microbiota profile between D0 and W6 in the FMT ( p = 0.07) but not the sham ( p = 0.7) group (Fig. 3 b).

The NC group showed a trend toward the lowest relative abundance of Pseudomonadota on d 20 ( P = 0.07).

PIK3CA -mutant PDX models showed a trend toward an improved response to alpelisib as well (one-tailed p = 0.07).

NETs’ levels inversely correlated with CD8 + T-cell density ( R = –0.33, p = 0.025) and showed a trend toward positive correlation with CAFs ( R = 0.27, p = 0.07).

Intratumoral CD163 + TAMs showed a trend in differences for RFS ( P = 0.07, log-rank test) and OS ( P = 0.07; Fig. 3A ), although the results did not reach statistical significance.

Preoperative endoscopic assessment showed a trend toward a larger HH size in the mesh group (4.1 vs. 3.4; p = 0.07).

Although not statistically significant, children receiving allometric dosing showed a trend ( P = .07) for much more rapid miltefosine accumulation than children on conventional dosing, with median day-7 plasma concentrations of 5.88 μg/mL (range 0.66–14.3 μg/mL) versus 2.67 μg/mL (range 0.70–12.8), respectively.

First, we looked at CR/CRi status at FU90 and found a trend for an association of chromatin-modifier mutations with a higher CR/CRi rate ( p = 0.07), whereas mutations in tumor-suppressor genes showed a trend for a lower CR/CRi rate ( p = 0.07) ( Supplementary Table S4 ).

Patients who had received BRAF and MEK inhibitors treatment prior to the study showed a trend toward worse survival ( p = 0.07): for this group, 12-month and 24-month OS rates were 46% and 16%, respectively.

The ultimate attainment analysis on the fifth bin showed a trend towards an interaction between valence and probability, F (1, 82) = 3.28, p = .07, η2 = 0.04.

(absent in CON-0, but 5% in CIDR groups and around 11.1% in SP groups), although differences only showed a trend for SP groups when compared to CON-0 ( p = 0.07).

In addition, the VOC profiles from method 1 showed a trend of discrimination between asthmatics with versus without atopy (p=0.07), whereas such discrimination was not apparent using methods 1 and 2 (p>0.77).